Overexpression of HIF-1α has been shown to be associated with tumor cell growth in patients with cervical, endometrial, gastric, colorectal, pancreatic, ovarian, breast, and head/neck carcinomas [33–37]. This evidence concerns the gene HIF1A and head and neck carcinoma.